• Issue

    European Journal of Haematology: Volume 85, Issue 1

    1-92
    July 2010
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Articles

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment

Meletios A. Dimopoulos,  Dimitrios Christoulas,  Maria Roussou,  Efstathios Kastritis,  Magdalini Migkou,  Maria Gavriatopoulou,  Charis Matsouka,  Despoina Mparmparoussi,  Erasmia Psimenou,  Irini Grapsa,  Eleni Efstathiou,  Evangelos Terpos, 
  • Pages: 1-5
  • First Published: 15 June 2010

Central nervous system involvement in diffuse large B-cell lymphoma

Wataru Yamamoto,  Naoto Tomita,  Reina Watanabe,  Yukako Hattori,  Yuki Nakajima,  Rie Hyo,  Chizuko Hashimoto,  Shigeki Motomura,  Yoshiaki Ishigatsubo, 
  • Pages: 6-10
  • First Published: 15 June 2010

Clinical outcome of patients with follicular lymphoma and bulky disease after Rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy

Fabienne McClanahan,  Thomas Hielscher,  Michael Rieger,  Manfred Hensel,  Kai Neben,  Jens Hillengass,  Klaus Herfarth,  Anthony D. Ho,  Mathias Witzens-Harig, 
  • Pages: 11-19
  • First Published: 15 June 2010

Frequency of congenital dyserythropoietic anemias in Europe

Hermann Heimpel,  Andreas Matuschek,  Momin Ahmed,  Brigitte Bader-Meunier,  Adriana Colita,  Jean Delaunay,  Loic Garcon,  Florinda Gilsanz,  Jeroen Goede,  Josef Högel,  Elisabeth Kohne,  Rosi Leichtle,  Juan Munoz,  Silverio Perrotta,  Carlo Piscopo,  Raffaele Renella,  Klaus Schwarz,  Gabriela Smolenska-Sym,  Sunitha Wickramasinghe,  Alberto Zanella,  Achille Iolascon, 
  • Pages: 20-25
  • First Published: 15 June 2010

Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells

Michiyo Kobayashi-Sakamoto,  Emiko Isogai,  Ingunn Holen, 
  • Pages: 26-35
  • First Published: 15 June 2010

Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study

Paolo Ricchi,  Massimiliano Ammirabile,  Anna Spasiano,  Silvia Costantini,  Patrizia Cinque,  Tiziana Di Matola,  Leonilde Pagano,  Luciano Prossomariti, 
  • Pages: 36-42
  • First Published: 15 June 2010

Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration

Michelle A. Elliott,  Louis Letendre,  Dennis A. Gastineau,  Jeffrey L. Winters,  Rajiv K. Pruthi,  John A. Heit, 
  • Pages: 43-50
  • First Published: 15 June 2010

Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload

Jane S. Hankins,  Matthew P. Smeltzer,  M. Beth McCarville,  Banu Aygun,  Claudia M. Hillenbrand,  Russell E. Ware,  Mihaela Onciu, 
  • Pages: 51-57
  • First Published: 15 June 2010

Sepsis in acute myeloid leukaemia patients receiving high-dose chemotherapy: No impact of chitotriosidase and mannose-binding lectin polymorphisms

Anja Klostergaard,  Rudi Steffensen,  Jens K. Møller,  Niels Peterslund,  Caroline Juhl-Christensen,  Ingolf Mølle, 
  • Pages: 58-64
  • First Published: 15 June 2010

Vitamin D deficiency does not alter biochemical markers of bone metabolism before or after autograft in patients with multiple myeloma

Michel Laroche,  Olivia Lemaire,  Michel Attal, 
  • Pages: 65-67
  • First Published: 15 June 2010

The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells

Homare Eda,  Katsuhiko Aoki,  Soki Kato,  Yutaka Okawa,  Koji Takada,  Takaaki Tanaka,  Keishi Marumo,  Kiyoshi Ohkawa, 
  • Pages: 68-75
  • First Published: 15 June 2010

Case Report

Organising pneumonia mimicking invasive fungal disease in patients with leukaemia

Fabio Forghieri,  Leonardo Potenza,  Monica Morselli,  Monica Maccaferri,  Letizia Pedrazzi,  Patrizia Barozzi,  Daniela Vallerini,  Giovanni Riva,  Eleonora Zanetti,  Chiara Quadrelli,  Giulio Rossi,  Francesco Rivasi,  Massimino Messino’,  Fabio Rumpianesi,  Antonella Grottola,  Claudia Venturelli,  Monica Pecorari,  Mauro Codeluppi,  Giuseppe Torelli,  Mario Luppi, 
  • Pages: 76-82
  • First Published: 15 June 2010

Letters to the Editor

Lymphomatoid granulomatosis developing from chronic active Epstein–Barr virus infection in a patient with myelodysplastic syndrome

Ai Mihara,  Tsunayuki Kakimoto,  Kazuhito Suzuki,  Yukinari Sanada,  Michio Iwabuchi,  Yoshinobu Aisa,  Sachiko Yoshida,  Tomonori Nakazato, 
  • Pages: 83-85
  • First Published: 15 June 2010

Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia

Ayalew Tefferi,  Ralph Levitt,  Terra L. Lasho,  Ryan A. Knudson,  Rhett P. Ketterling, 
  • Pages: 86-87
  • First Published: 15 June 2010

Refinements in response criteria in systemic mastocytosis: reply to a proposal

Peter Valent,  Cem Akin,  Wolfgang R. Sperr,  Hans-Peter Horny,  Dean D. Metcalfe, 
  • Pages: 88-89
  • First Published: 15 June 2010

Response criteria in systemic mastocytosis: moving forward with practical assessment that reflects meaningful health outcome

Animesh Pardanani,  Ayalew Tefferi, 
  • Page: 90
  • First Published: 15 June 2010

Clinical Picture

Haemophagocytic syndrome and Hodgkin’s disease variant of Richter’s syndrome after fludarabine for CLL

Layal Chaker,  Christine M Segeren,  Freek J Bot,  Eduard Maartense, 
  • Pages: 91-92
  • First Published: 15 June 2010